Dr Hopkins is an experienced bio-pharmaceutical executive with over 20 years in leadership roles with public biotechnology companies.
With an established track record in drug development of novel therapies focussed in oncology and medicinal cannabis, corporate strategy and financing business development and intellectual property.
Dr Hopkins recently served as the Managing Director for Zelira Therapeutics and CEO at PharmAust. Also, a co-founder of Phylogica, where, in addition to the CEO role, he served in variety of positions, including Chief Scientific Officer, and Chief Operating Officer.
Dr Hopkins has managed and overseen strategic alliances and licensing deals with multiple global pharmaceutical partners including J&J, Pfizer, Roche, Genentech, AstraZeneca/Medimmune, generated over $14 million in revenues as well as building and launching strong proprietary pipelines.
Dr Hopkins is an author on over 30 peer-reviewed publications and is an inventor on 15 patents and patent applications.